Telegraph

7x24 real-time news feed, auto refreshBeijing Time：

🔄 Auto refresh 🔔 Sound 💬 Notify

All A·Important B·Normal #A-share risk warning announcement ✕

[Fangda Special Steel: Plans to withdraw from Nanchang Huxu and acquire 100% equity of Jiangxi Fangda Steel Group Enterprise Investment Company] On October 16th, Fangda Special Steel (600507.SH) announced that the company, as a limited partner of Nanchang Huxu, plans to withdraw from Nanchang Huxu and distribute in kind and cash The company acquired 100% of the equity of Jiangxi Fangda Iron and Steel Group Enterprise Investment Co., Ltd. held by Nanchang Huxu through gold purchase. Among them, the equity ratio of the target company acquired in the form of physical distribution was 99.2626%, and the equity ratio of the target company acquired in the form of cash purchase was 0.7374%. The above transactions constitute a major asset reorganization and related transactions. 99.2626% of the equity of Fangda Qi Investment was transferred to Fangda Special Steel in the form of physical distribution, and no additional consideration was required for this part of the equity. The transaction consideration was calculated based on the listed company's paid-in capital contribution as a limited partner of Nanchang Huxu, which was RMB 3.5 million; the transaction price of Fangda Qitou's 0.7374% equity was RMB 26 million.

#A-share announcement express #A-share risk warning announcement10-16 22:14

[Yinhe Microelectronics: Plans to purchase 100% equity of Hengtike Transaction price 645 million yuan] On October 16, Galaxy Microelectronics (688689.SH) announced that the company plans to purchase 100% of the equity of Hengtike held by three shareholders, Shanghai Zhineng Hengxin Industrial Electronics Co., Ltd., Gongqingcheng Mingnuo Investment Partnership (Limited Partnership), and Tianmu Yulin (Shanghai) Technology Co., Ltd., and raise supporting funds through the issuance of shares. The transaction price is 645 million yuan. The target company Hengtike is a national-level specialized and new "little giant" enterprise mainly engaged in the research, development, and sales of power semiconductor products and providing related technical consulting and technical services. Its products are widely used in engineering machinery, drones, photovoltaics, energy storage and other fields.

#semiconductor #drone #A-share announcement express #A-share risk warning announcement10-16 17:58

[4-Connect Ciwen Media: The micro-short drama "The Battle of the Bid Opening" has a relatively small investment scale The income attributable to the company it has generated so far is about 500,000 yuan] On October 14th, Ciwen Media (002343.SZ) announced that the investment scale of the company’s recently produced micro-short drama "The Battle of the Bid Opening" is relatively small. The income attributable to the company it has generated so far is about 500,000 yuan. It is expected to account for a relatively small proportion of the company’s overall operating income in the future and will not have a major impact on the company’s operating performance. The company's short drama business is small in scale, and its profit in 2025 will be a loss; the company's overseas business is also small in scale, accounting for less than 1% of its revenue. As of the date of this announcement, the company's AIGC platform has not yet generated relevant revenue; it is expected that this business will not have a significant impact on the company's production, operations and financial status in the future.

#AIGC #A-share announcement express #A-share risk warning announcement10-14 21:54

[Shengshi Technology: The humanoid robot business is advancing in an orderly manner Revenue in the first half of the year does not exceed 2%] On October 14th, Shengshi Technology (002990.SZ) issued an announcement on abnormal stock trading fluctuations, regarding the intelligent computing business that the market is concerned about. The intelligent computing business is a new business of the company. The advancement of the intelligent computing business is affected by industry policies, market environment, technological progress, customer operations, etc. Affected by factors, there is uncertainty about whether it can continue to maintain rapid growth; regarding the humanoid robot business that the market is concerned about, the company's humanoid robot business is advancing in an orderly manner. In the first half of 2026, the operating income of humanoid robots will account for no more than 2% of the company's operating income, and will not have a significant impact on the company's operating performance.

#humanoid robot #robot #A-share risk warning announcement #A-share announcement express10-14 19:58

[3 days and 2 boards Laimei Pharmaceutical: Nanocarbon-iron combined radiotherapy is still in phase II clinical trials] On October 14th, Laimei Pharmaceutical (300006.SZ) issued an announcement of abnormal stock trading fluctuations. The company is concerned that the market and media have recently paid attention to the clinical trials of the company’s nanocarbon-iron suspension injection (CNSI-Fe) (referred to as nanocarbon-iron). This matter is mainly due to the company's holding subsidiary Ingrui Medicine recently publishing academic papers on the Phase I clinical trial of its independently developed nanocarbon iron in relevant academic journals, as well as the interpretation of clinical trial results or individual case results disclosed by relevant partner hospitals. As of now, nanocarbon iron combined with radiotherapy is still in the phase II clinical trial stage. Subsequently, the results of the phase II clinical trial of combined radiotherapy must be used to advance the application for breakthrough therapy designation, or conduct phase III clinical trials, apply for drug marketing authorization (NDA) and other core links. There are major uncertainties in the above-mentioned core links, and there are risks such as the results of phase II clinical trials not meeting expectations, the inability to apply for or be approved for breakthrough therapy designation, the inability to conduct or complete phase III clinical trials, the inability to submit or approve NDA, and the delay in review and approval progress.

#clinical trial #A-share announcement express #A-share risk warning announcement10-14 18:29

[*ST Hi-tech: Hainan Innovation has not refunded the 50 million yuan deposit so far and the public security agency has opened a case] On October 14th, *ST Hi-Tech (600730.SH) announced that the company's previously disclosed 50 million yuan deposit for the exclusive negotiation of the Shenzhen Core Energy Semiconductor Project has not been recovered as scheduled. Although Hainan Innovation has been asked to return it through various channels such as reminder letters and lawyer's letters, the money has not been returned yet. The company initially reported the case to the Haidian Branch of the Beijing Municipal Public Security Bureau on the grounds that funds had been misappropriated. Recently, it received a "Notice of Case Filing" and the case has been filed. At present, the production and operation of the company and its subsidiaries are in normal order, and the above matters will not have a significant impact on daily production and operations. If the amount cannot be recovered for a long time, the company will accrue credit impairment losses, and related bad debt losses will have a negative impact on profits and losses.

#semiconductor #A-share announcement express #A-share risk warning announcement10-14 18:03

[2 consecutive Jishi Media: AI micro-short drama business has not yet generated stable income] On October 12th, Jishi Media (601929.SH) issued a change announcement. The company paid attention to relevant media reports on the company’s AI micro-short drama business. The company's related businesses are still in the initial cultivation and model polishing stage, and have not yet generated stable income. The income is extremely low and is not expected to have a significant impact on the company's performance this year. Investors are advised to pay attention to investment risks.

#A-share announcement express #A-share risk warning announcement10-12 20:42

[2-Link Ciwen Media: The AIGC platform is still under construction and related projects are being prepared and advanced] On October 12th, Ciwen Media (002343.SZ) issued an announcement of abnormal stock trading fluctuations. As of the announcement date, the company's AIGC platform is still under construction and improved, and related projects are being prepared and advanced, and relevant revenue has not yet been generated; in the future, there are uncertainties in the construction and operation of the AIGC platform, related business progress, and the impact on the company's production operations and financial status.

#AIGC #A-share announcement express #A-share risk warning announcement10-12 20:29

[Jinyi Technology: The related business income of low-altitude intelligent connection and Chelu Cloud business accounts for less than 5% of the company's overall operating income] On October 12, Jinyi Technology (002869.SZ) issued a change announcement. As of June 30, 2026, the related business income of the company's low-altitude intelligent connection and Chelu Cloud business accounted for less than 5% of the company's overall operating income, which has not yet had a significant impact on the company's current operating performance.

#A-share announcement express #A-share risk warning announcement10-12 20:22

[2-Connect Board Huanrui Century: The company's AI short drama business has not yet formed a scale effect in terms of online quantity, revenue scale and cost-effective transformation] On October 12th, Huanrui Century (000892.SZ) announced that the company's stock closing price increase deviation exceeded 20% for two consecutive trading days (October 9th and October 12th), which is an abnormal fluctuation in stock trading. Up to now, the company's AI short drama business has not yet achieved scale effects in terms of online quantity, revenue scale and cost-effective transformation. In the first half of 2026, the company's AI short drama business operating income accounted for less than 1% of the overall unaudited operating income in the first half of 2026. The company's AIGC-related business revenue accounts for a low proportion and does not have a significant impact on short-term operating performance.

#AIGC #A-share announcement express #A-share risk warning announcement10-12 19:09

[Decai Shares, 3 boards in 4 days: Fantasy Infinite, its controlling subsidiary, is still at a loss] On October 12, Decai Shares (605287.SH) announced that the company has noticed that concepts related to comic drama production have become more popular in the capital market recently, and the secondary market performance of related sectors has been relatively active. Some media reported that the company’s controlling subsidiary, Fantasy Infinite, is involved in related concepts. Qixiang Wuxian was established on December 5, 2025. In the first half of 2026, Qixiang Wuxian achieved operating income of 24.5709 million yuan and a net profit of -5.6217 million yuan. It is still in the business development stage, the revenue scale is small and it is still in a state of loss, which has not had a significant impact on the company's operating performance.

#A-share announcement express #A-share risk warning announcement10-12 18:54

[2-Connected Yuanban Shares: Planning to acquire control of a certain enterprise] On October 12th, Yuanyuan Shares (002692.SZ) issued a change announcement. The company is currently planning to acquire control of a certain enterprise with self-raised funds. It is not expected to constitute a related transaction or major asset restructuring. The matter is in the planning and due diligence stage. No agreement has yet been signed, and there are major uncertainties. After verification, the company is operating normally and there are no other major matters that should be disclosed but have not been disclosed by the controlling shareholder and actual controller.

#A-share announcement express #A-share risk warning announcement10-12 18:17

[2nd Board Geer Software: The company is currently deepening the integration of AI and core business, and the proportion of related business revenue is low] On October 12, Geer Software (603232.SH) issued an announcement of abnormal stock trading fluctuations. The company has noticed the recent market attention to the company’s network security concept. The company is currently deepening the integration of AI and core business, and the proportion of related business revenue is low. Currently, Lu Haitian, one of the actual controllers of the company, is in the period of reducing his holdings (from September 10, 2026 to December 9, 2026), and Lu Haitian’s holding reduction plan has not yet been completed.

#network security #software #A-share announcement express #A-share risk warning announcement10-12 17:33

[Jindan Technology: An 8% increase in the sales price of lactic acid series products is not expected to have a significant impact on the company’s operating performance in 2026] On October 12, Jindan Technology (300829.SZ) issued a stock price change announcement. The company’s current main business The company's business is the production and sales of lactic acid and its series of products. The company's new polylactic acid biodegradable material project with an annual output of 75,000 tons is still in the trial stage. There is uncertainty about the project's commissioning and production capacity release time. Investors are kindly requested to invest rationally and pay attention to investment risks. The company issued a price adjustment notice to customers on October 10, 2026, and the sales price of the company's lactic acid series products (including lactic acid, lactate, etc.) will be increased by 8% on the existing basis. There are uncertainties in the implementation progress and customer acceptance after this price adjustment. If some customers reduce their purchases after the price adjustment, the sales volume of the company's related products may decline; since this price adjustment will be implemented from October 10, 2026 and will be implemented within a short time, it is not expected to have a significant impact on the company's operating performance such as gross profit in 2026. Investors are kindly requested to invest rationally and pay attention to investment risks.

#A-share announcement express #A-share risk warning announcement10-12 17:09

[2-connected board Vision Technology Co., Ltd.: The solid-state battery business has not yet entered the mass production stage] On October 11, Vision Technology Co., Ltd. (002733.SZ) issued a change announcement. The company's solid-state battery business is still in the research and development and pilot verification stages, has not yet entered the mass production stage, and has not generated sales revenue. It will not have a significant impact on the company's overall performance for the time being. Affected by factors such as macroeconomics, industry policies, market environment changes, construction project progress and other factors, the project also faces the risk that industrialization and commercialization will not meet expectations.

#A-share announcement express #A-share risk warning announcement10-11 15:44

[2 consecutive boards of Sanboshuo: It is not directly involved in the sports event business, nor is it involved in hot concepts related to this sports event] On October 9th, Sanboshuo (001300.SZ) issued an announcement of abnormal stock trading fluctuations. After verification by the company, the market has recently paid more attention to concepts related to sports events. The company's main business is the research and development, design, production and sales of leisure sports and fitness equipment series products. It does not directly involve the sports event business, nor does it involve hot concepts related to this sports event, and will not have a significant impact on the company's stock trading price.

#A-share announcement express #A-share risk warning announcement10-09 20:46

[2 consecutive North China Pharmaceuticals: Injectable streptomycin sulfate sales revenue is small] On October 9th, North China Pharmaceuticals (600812.SH) announced that the company's stock had a cumulative deviation of 20% from the closing price increase for three consecutive trading days on September 30, October 8, and October 9, 2026, which was an abnormal fluctuation in stock trading. The company is concerned that the market has recently paid high attention to hot concepts related to "plague". After verification, the company's instructions for Streptomycin Sulfate for Injection show that its indications include the treatment of tularemia alone, or in combination with other antibacterial drugs for the treatment of plague, inguinal granuloma, brucellosis, rat-bite fever, etc. This product is a traditional antibiotic variety of the company. The sales revenue of this product in 2025 and January-June 2026 will be small and will not have a significant impact on the company's overall operating performance. Except for the above, the Company has not found any other media reports or market rumors that may have a significant impact on the trading price of the Company's shares.

#antibiotic #A-share announcement express #A-share risk warning announcement10-09 18:59

[2-connected Fengyuan Shares: Participating in solid-state battery manufacturing companies but with a low shareholding ratio and not involved in the battery production business] On October 9th, Fengyuan Shares (002805.SZ) issued a change announcement. The company is concerned that the concept of solid-state batteries has received high market attention recently. Currently, the company's main business is lithium-ion battery cathode material business and oxalic acid business. It does not involve battery production business and there is no related business income. The company has carried out forward-looking research and development layout in the field of solid-state battery cathode materials, and has taken shares in solid-state battery manufacturing companies. However, the shareholding ratio is relatively low and is not included in the company's consolidated statements. It will not have a significant impact on the company's current main business and operating performance.

#A-share announcement express #A-share risk warning announcement10-09 18:56

[4-plate Zizhu Hi-Tech: Aluminum-plastic film products for lithium batteries and solid-state battery concept-related businesses are still in the early stages of exploration and research and development] On October 9, Zizhu Hi-Tech (002058.SZ) issued a change announcement. The company is concerned that the concept of "solid-state batteries" has received widespread attention from the market recently. As of now, the company's aluminum-plastic film products for lithium batteries and business related to the above concepts are still in the early stages of exploration and research and development. There is great uncertainty as to when it will be commercialized in the future and provide the company with stable, large-scale revenue. Investors are kindly requested to pay full attention to the above uncertainties, invest rationally and pay attention to investment risks.

#Lithium battery #A-share announcement express #A-share risk warning announcement10-09 18:54

[5-plate Times Wanheng: The company's products do not involve solid-state batteries] On October 9th, Times Wanheng (600241.SH) issued a stock trading risk warning announcement. The company's lithium battery products are small power cylindrical ternary lithium batteries, which are mainly used in the field of small power tools, with 1865 and 1450 as the main products; nickel-metal hydride battery products are mainly used in personal care, consumer goods, power tools and other fields. The company's products do not involve solid-state batteries. The company's current production and operations are operating normally, and production is organized according to orders. As of the disclosure date of this announcement, the company's existing main products and production lines have not changed, and there have been no major changes in the fundamentals of production and operations.

#Lithium battery #A-share announcement express #A-share risk warning announcement10-09 16:06

[Eight-Continuous Board Xinhua Media: If the company's stock price rises further abnormally, the company may apply for trading suspension and verification] On October 8, Xinhua Media (600825.SH) announced that the company's stock has been at the daily limit for eight consecutive trading days from September 21 to October 8, 2026, with a cumulative increase deviation of 117.06%, which is a serious abnormal fluctuation in stock trading. The company's fundamentals have not changed significantly, but recently the company's stock price has seriously deviated from the company's fundamentals. Investors participating in transactions may face greater risks. If the company's stock price rises further abnormally, the company may apply for a trading suspension for verification.

#A-share announcement express #A-share risk warning announcement10-08 21:23

[Jin Longyu: The company’s solid-state battery business is still in the stage of production capacity construction and downstream customer expansion] On October 8, Jin Longyu (002882.SZ) announced that the company’s stock’s daily closing price increase deviation exceeded 20% in three consecutive trading days on September 29, September 30, and October 8, 2026, which was an abnormal fluctuation in stock trading. The company's solid-state battery business is still in the stage of production capacity construction and downstream customer expansion. Although it has received small batch orders, it has not yet formed long-term stable income, and it will not have a significant impact on the company's overall performance for the time being. Affected by factors such as macroeconomics, industry policies, market environment changes, construction project progress and other factors, the project also faces the risk that industrialization and commercialization will not meet expectations.

#A-share announcement express #A-share risk warning announcement10-08 18:26

[Weike Technology: The company's sodium-ion battery-related business currently accounts for a relatively small proportion of the business] On October 8, Weike Technology (600152.SH) issued an announcement of abnormal stock trading fluctuations. After verification by the company, the market has recently paid more attention to sodium-ion battery-related concepts. The sodium-ion battery industry as a whole is still in the early stages of industrialization, and there are still uncertainties in the technical route and market promotion progress. The company's sodium-ion battery-related business currently accounts for a relatively small proportion of the business, and it will still take a certain period of time to achieve large-scale commercialization. The related business's contribution to the company's overall performance for the current period is extremely limited, and it is difficult to have a significant impact on the company's operating performance in the short term.

#A-share announcement express #A-share risk warning announcement10-08 17:16

[Xinya Processing: Not engaged in the R&D and production of all-solid-state battery materials and electrolyte products] On October 7, Xinya Processing (002388.SZ) issued an announcement of abnormal stock trading fluctuations. The company is not engaged in the R&D and production of all-solid-state battery materials and electrolyte products, and semi-solid battery products have not generated operating income. The company's business does not involve the research, development and production of vinylene carbonate. The company's output of lithium hexafluorophosphate in 2025 will be 1,119.60 tons, and its external sales will be 363.48 tons. The operating income generated by the external sales part will be 27.8693 million yuan, accounting for 1.44% of the company's 2025 operating income. From January to June 2026, the output of lithium hexafluorophosphate was 1,682.49 tons, and the external sales were 921.53 tons. The operating income achieved by the external sales part was approximately 83.45 million yuan. It will account for approximately 9% of the company's operating income in the first half of 2026, and its contribution to the company's operating income will be limited. This business may face the impact of uncertain factors such as industry policies and market environment in the future. There may be risks such as industry cycles and market competition, and the impact on the company's future performance is uncertain.

#A-share announcement express #A-share risk warning announcement10-07 18:34

[Nearshore Protein: AI-enabled high-throughput wet experiments and data package services are still in the early stages of market expansion] On October 7, Nearshore Protein (688137.SH) issued a serious abnormal stock trading fluctuation and risk warning announcement. The company's 2025 RNA vaccine drug-related product revenue will account for 11.38% of total product revenue, which is a relatively low proportion. The company's AI-enabled high-throughput wet experiments and data package services are still in the early stages of market expansion, and as of the first half of 2026, related business revenue will account for less than 2% of the company's overall operating income. Given that the application of AI in the drug R&D industry is still in its infancy, there are risks such as rapid technology iteration, long industry verification cycles, and difficulty in commercialization, and there are significant uncertainties in the company's future related revenue and profit realization.

#drug research and development #RNA #Qualcomm #vaccine #A-share announcement express #A-share risk warning announcement10-07 17:58

[JAC: There is indeed an intention to discuss cooperation with Huawei and Stellantis, but the content and form of cooperation have not been determined] On September 30, Jianghuai Automobile (600418.SH) announced that the company’s stock’s closing price increase deviation for three consecutive trading days on September 28, 29, and 30 exceeded a cumulative value of more than 20%, which was an abnormal fluctuation in stock trading. Recently, the company has noticed that some media have published reports on relevant media platforms that the company intends to cooperate with Huawei and Stellantis. After verification, the company, Huawei and Stellantis do have intentions to discuss cooperation. However, the content and form of cooperation have not been determined, and no binding formal agreement has been signed. There is still great uncertainty in the advancement of subsequent related cooperation matters.

#Huawei #A-share announcement express #A-share risk warning announcement09-30 21:38

[CanSino: It is developing mRNA preventive vaccines and therapeutic biological products, as well as the development of related delivery systems] On September 30, CanSino (688185.SH) issued an announcement of abnormal stock trading fluctuations. The company is concerned about the recent development of mRNA technology in the market, and overseas clinical phase data of mRNA tumor vaccines have been released or planned to be made public. The mRNA platform is one of the technology platforms deployed by the company. The company is developing mRNA preventive vaccines and therapeutic biological products, as well as related delivery systems. In terms of therapeutic areas, the company is advancing the research and development of mRNA vaccines for the treatment of indications such as glioblastoma, rhabdomyosarcoma and cervical cancer, as well as the development of InVivoCAR-related therapies, which are currently in early stages.

#vivo #RNA #cell #vaccine #A-share announcement express #A-share risk warning announcement09-30 18:48

[2-plate Shanghai Xiba: Solid-state battery related business has not yet formed long-term stable large-scale revenue] On September 30th, Shanghai Xiba (603200.SH) announced that the company is concerned that the solid-state battery concept has received high market attention in the near future. As of now, the company's related business has not yet formed long-term stable large-scale revenue; at the same time, based on the uncertainty of product iteration and market development, the detection, matching results and application prospects of related samples are also highly uncertain. Investors are advised to make careful decisions. Currently, the company's actual controller Weng Huilan is in the period of reduction of shares (September 24, 2026 to December 22, 2026), and Weng Huilan's share reduction plan has not yet been completed.

#A-share announcement express #A-share risk warning announcement09-30 18:27

[Lu Chang Technology: Controlling shareholder plans to change control and suspend trading from tomorrow] On September 29, Lu Chang Technology (002813.SZ) announced that the company's stock closing price increase deviation for three consecutive trading days has exceeded 20%, which is an abnormal fluctuation. After verification, the company is operating normally and there is no major information that has not been disclosed. The controlling shareholder plans to transfer control, and the company plans to suspend trading from September 30.

#A-share announcement express #A-share risk warning announcement09-29 20:37

[13 days, 7 boards, Zhongxinsike: AI security product-related revenue accounted for no more than 2% in the first half of the year] On September 29, Zhongxinsike (002912.SZ) issued an announcement of abnormal stock trading fluctuations. In response to the "AI security concept" that the market is paying attention to, the company's AI application products are based on the company's AIWorkForce platform and provide services such as AI application scenario development, agent deployment, and AI security governance for government and enterprise customers. At present, the market for such products is an emerging market and is still in the initial stage of commercialization. In the first half of 2026, the company's operating income from this type of products will account for no more than 2% of its overall operating income.

#agent #A-share announcement express #A-share risk warning announcement09-29 18:35